RMD Open

is an open access, peer-reviewed rheumatology journal that publishes original research on rheumatic and musculoskeletal disorders and connective tissue diseases

Impact Factor: 5.1
Citescore: 7.3
All metrics >>

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

Follow the journal on X for the latest updates.

Editorial team

Current Issue

Authors

RMD Open accepts submissions of a wide range of article types, including original research, analysis and practice articles, and commentaries.

The Author Information section provides specific article requirements to help you turn your work into an article suitable for RMD Open.

Information is also provided on editorial policies and open access.

Author information Submit a paper

Latest Articles

Spondyloarthritis:

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis

31 December 2024

Vasculitis:

Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies

31 December 2024

Osteoarthritis:

Synovitis scoring in hand osteoarthritis with ultrasonography: the performance of the Global OMERACT/EULAR Ultrasound Synovitis Score (GLOESS) is comparable to synovial thickening alone

31 December 2024

Lupus:

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus

31 December 2024

Rheumatoid arthritis:

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study

31 December 2024

VACANCY: Editor-in-Chief

BMJ Group seeks an ambitious and dynamic Editor-in-Chief for its leading rheumatology journal, RMD Open from 2026.

The successful candidate should have stature in the field of rheumatology and a distinguished publication record, as well as experience of working in a senior editorial role on an academic journal.

International and joint applications are encouraged.

Application deadline: 2nd March 2025

Find out more and how to apply